Type I IFNs and their role in the development of autoimmune diseases. - Wikidata - wikimedia - TriplyDB

Type I IFNs and their role in the development of autoimmune diseases.

Type I IFNs and their role in the development of autoimmune diseases.

http://www.wikidata.org/entity/Q37528458

about

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients Immunogenicity and other problems associated with the use of biopharmaceuticals.Safety, Tolerability, and Immunogenicity of Interferons The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.Diabetes and Hepatitis C: A Two-Way Association.Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.Type I IFN gene delivery suppresses regulatory T cells within tumors.Hepatitis C virus treatment complicated by rheumatoid arthritis.Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece.

P2860

Q28290930-1D393B52-DF19-4257-914D-4C0570DBA3A6 Q33416851-2975E747-3CF2-4160-9DD7-6ABB1F71C9F3 Q33435810-96B95D3A-1CA2-485E-AE79-6BD81700EBA0 Q33962438-DBD5CCC1-5CC6-43B6-8BB9-79DBA4F43FF6 Q36056076-95F0182C-B2E7-4C6C-ADBD-7DD649A313FD Q37086396-22D6251C-FAD2-4A28-8DBD-489DAF50CF4F Q38937281-FDBA51C4-E92C-4670-ACE9-BFEF8961D2E9 Q40622385-8BB3E7FE-2D95-41E3-BC48-0E90C2252540 Q45259713-16C971C8-6397-4F99-AB2F-09A80ABD97A5

P2860

Type I IFNs and their role in the development of autoimmune diseases.

http://www.wikidata.org/entity/Q37528458

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Type I IFNs and their role in the development of autoimmune diseases.

@en

Type I IFNs and their role in the development of autoimmune diseases.

@nl

type

label

Type I IFNs and their role in the development of autoimmune diseases.

@en

Type I IFNs and their role in the development of autoimmune diseases.

@nl

prefLabel

Type I IFNs and their role in the development of autoimmune diseases.

@en

Type I IFNs and their role in the development of autoimmune diseases.

@nl

P1433

Q37528458-A5416CC8-9206-4131-B471-86BEB977FFDF

P1476

Q37528458-351CD13D-CFDF-4B63-AA07-E330A701205B

P2093

Q37528458-4F10A745-00B2-4DDA-A019-408B9ACB7D4E

Q37528458-6D1A4D82-2EA9-4E7C-9069-11901FE1C20E

Q37528458-E6CBC6E6-08EB-4216-8F3E-B1E045E0BF4E

P2860

Q37528458-01D4FBB6-9BEB-4B6A-8859-85E698CD4330

Q37528458-05213F4D-9EDE-4C6A-A4B1-061D4F75A5AE

Q37528458-05E8F0CF-678B-4DA2-8713-321052B07ADA

Q37528458-0C54D37E-1836-472E-8A0F-E32DCF52EF5B

Q37528458-0CA47843-E941-49D5-B560-3527DE2DA342

Q37528458-0CC8139F-1280-4529-9198-EC81E241EE5E

Q37528458-13CA89A9-762E-4CC4-A517-D9012D3CCB0A

Q37528458-171EAA6F-7B91-4BA1-96E6-0AEF6E6598FA

Q37528458-17683B47-FD5F-445C-B4A8-B59D78ECC1F9

Q37528458-18B77880-613D-4700-A8AC-9D6B2A3BF0BD

P304

Q37528458-D76C7BEB-A9C9-4AD8-AE44-A6C99409C2C3

P31

Q37528458-0A43E44C-E591-4964-B945-84D1EEE177C1

P356

Q37528458-5D881FCE-B40F-4C87-9998-8368B0082E3E

P407

Q37528458-92802AB9-9F13-4DA2-A7DA-19F120974F27

P433

Q37528458-115AD3FF-545A-49B4-A405-BB0BF8406BEF

P478

Q37528458-C66AD4B1-979A-4ED8-89C5-4DE1E7170CD2

P577

Q37528458-5A012CE1-6BEC-46AE-AABF-DDEECECF8403

P698

Q37528458-BE6BE5D6-873E-4195-9048-D9526F78294D

P356

14740330903066726

P1433

Expert Opinion on Drug Safety

P1476

Type I IFNs and their role in the development of autoimmune diseases.

@en

P2093

Ally-Khan Somani

http://www.w3.org/2001/XMLSchema#string

Laura M Burdick

http://www.w3.org/2001/XMLSchema#string

Najwa Somani

http://www.w3.org/2001/XMLSchema#string

P2860

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

Protein ISGylation modulates the JAK-STAT signaling pathway

Microarray analysis of gene expression in lupus

The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C

High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction.

Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

Interferons at age 50: past, current and future impact on biomedicine

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

P304

459-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740330903066726

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19548860

http://www.w3.org/2001/XMLSchema#string